Press Room

News / Sep 26, 2018

Hovione New Jersey Site Expansion - Opening Ceremony

Hovione invests over €30m in the USA

New Jersey Site Expansion CDMO Continuous Manufacturing | Hovione

On September 26th, 2018, Hovione New Jersey held the Opening Ceremony of the site expansion. This expansion is the result of an investment over €30 million in its R&D Center.

The Mayor of East Windsor, New Jersey, Janice S. Mironov, the Hovione CEO, Guy Villax and the AICEP Commissioner in the USA, Manuel Couto Miranda were present. The new R&D center represents an expansion of the range of Hovione's service offering in the US market and includes state-of-the-art technologies in the particle engineering and continuous manufacturing areas.

 

Learn More:

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025